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Abstract
A number of studies have suggested that stress-echocardiography may be used for prognostic
stratification in patients with idiopathic dilated cardiomyopathy. There is no consensus on which
protocol or which measurements of left ventricular contractile reserve to use. The most frequently
used protocol is low-dose dobutamine stress-echocardiography, and most commonly used
measures of left ventricular systolic performance are ejection fraction, wall motion score index and
cardiac power output.
Stress-echocardiography has been shown to predict improvement in cardiac function in patients
with recently diagnosed dilated cardiomyopathy, as well as to predict which patients will benefit
from the treatment with beta-blockers. Most importantly, stress-echocardiography can identify
patients with worse prognosis in terms of cardiac death and need for transplantation. Additionally,
contractile reserve is closely correlated with maximal oxygen consumption and can even be used
for further stratification in patients with maximal oxygen consumption between 10 and 14 ml/kg/
min.
Future studies are needed for head-to-head comparison of various protocols in an attempt to make
standardization in the assessment of patients with dilated cardiomyopathy.
Epidemiologic data from United States indicate that idio-
pathic dilated cardiomyopathy (DCM) is diagnosed in
approximately 36/100.000 persons each year, and that it
is responsible for more than 10.000 deaths per year [1].
Faced with the fact that the number of patients with DCM
is constantly increasing [2], accurate assessment of
patient's current status and prognosis is of the utmost
importance for the implementation of optimal therapeu-
tic algorithm as well as for the optimal utilization of
resources.
Why stress-echocardiography?
There is a widespread belief that maximal oxygen con-
sumption, assessed by cardiopulmonary testing, is one of
most, if not the most important prognostic variables in
DCM patients [3]. Maximal oxygen consumption is tradi-
tionally used for selection of patients for cardiac
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indicating poor prognosis and need for transplantation
[4,5]. This approach is based upon assumption that max-
imal oxygen consumption during cardiopulmonary test-
ing is determined exclusively by cardiovascular factors.
However, it appears that other factors have considerable
influence on maximal oxygen consumption, since it has
been shown that regular physical exercise can augment
oxygen consumption with little or no impact on other
parameters of cardiovascular function [6]. Additionally, a
normal blood flow through lower limbs was found in
patients who stopped cardiopulmonary testing because of
fatigue, indicating skeletal muscle dysfunction rather than
pump failure [7] Patient's age and sex, as well as muscle
mass are also shown to have strong influence on perform-
ance during cardiopulmonary testing [8]. Furthermore, it
appears that patients with various degrees of cardiovascu-
lar impairment may yield similar maximal oxygen con-
sumption, suggesting that there is a role for other
procedures in risk stratification of patients with DCM [9].
A number of studies have shown that assessment of ven-
tricular contractile reserve by means of stress-echocardiog-
raphy may refine prognosis in patients with left
ventricular systolic dysfunction [10-12]. Nevertheless,
stress-echocardiography is widely underused in routine
work-up in patients with heart failure, probably because
of the unfamiliarity with the technique in this clinical
setting.
The aim of this review is to put stress-echocardiography in
DCM patients in clinical context, to give practical tips how
to perform it and what to measure, as well as to try to
define its role in everyday clinical practice.
How to perform stress-echocardiography in 
DCM?
Unlike protocols for stress-echocardiography for coronary
artery disease, there is no consensus about the protocol to
be used in patients with left ventricular systolic
dysfunction.
The majority of authors have used either low- or high-
dose dobutamine echocardiography [13,14]. Low-dose is
usually defined as 10 mcg/kg/min of dobutamine [13],
although some authors also consider 20 mcg/kg/min as a
low-dose infusion [15] High-dose is uniformly defined as
40 mcg/kg/min [10]. There is no consensus either on
duration of each stage of dobutamine infusion, since
some authors use 3-minute stage [16] while the others use
5-minute stage [10] Most authors withdraw beta-blockers
prior to stress-echocardiography, but some do not [15]
Atropine is generally not used to achieve submaximal
heart rate.
Exercise testing has been used for the assessment of left
ventricular contractile reserve but in conjuction with radi-
onuclide angiography [17] and hemodynamic measure-
ments [18]. The usual protocol is performed on supine
bicycle in incremental stages of 25 W lasting three min-
utes each. There are no data about the value of exercise
stress echocardiography in DCM patients. It can be
assumed that exercise stress-echocardiography would
have the same limitations as cardiopulmonary testing.
Dipyridamole stress-echocardiography has been pro-
posed for stratification of patients with DCM. Standard
high-dose dipyridamole protocol (0.84 mg over 10 min-
utes) has been used for the assessment of contractile
reserve [19].
What to measure?
All studies on stress-echocardiography in DCM measured
contractile reserve of the left ventricle. Contractile reserve
is defined as the difference between values of an index of
left ventricular contractility during peak stress and its
baseline values. There is no consensus on what index to
use.
Ejection fraction
This is the most frequently used index of left ventricular
performance. However, it may not accurately reflect left
ventricular contractility since it is heavily dependent on
loading conditions [20] which is particularly important in
patients with heart failure for the following reasons. First
of all, mitral regurgitation is frequent in these patients,
and can lead to overestimation of left ventricular contrac-
tility due to rise in ejection fraction caused by changes in
loading conditions (higher preload, lower afterload) [21]
Secondly, activation of neuroendocrine compensatory
mechanisms may increase afterload, which in turn may
subsequently decrease ejection fraction [22] Thirdly, left
ventricular preload is dependant upon interventricular
interaction which is exaggerated in cases of pulmonary
hypertension [23] a frequent finding in DCM patients.
Furthermore, dobutamine has variable influence on after-
load, since it has been shown that it may decrease after-
load by 10% in patients with mild heart failure, but may
also increases afterload by 5% in patients with severe
heart failure [24].
Despite all these potential drawbacks, the change in ejec-
tion fraction during stress has been shown to have crucial
prognostic significance in patients with DCM. It is gener-
ally accepted that increase in ejection fraction by ≥ 5% or
change from baseline ejection fraction by ≥ 20% during
stress-echocardiography identifies patients with preserved
left ventricular contractile reserve and better prognosis.
Ejection fraction should be assessed by Simpson biplane
formula.Page 2 of 8
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Wall motion score index has been traditionally used in
stress-echocardiography for the detection of coronary
artery disease [25]. Only two reports used this index of left
ventricular contractility to assess prognosis and functional
recovery of DCM patients [10,15]. Wall motion score
index was assessed in a standard manner, by using 16 seg-
ment model of the left ventricle according to the recom-
mendations given by American Society of
Echocardiography [26]. The major potential drawback for
use of this index is semiquantitive assessment of wall
motion, which is even more subjected to inter- and
intraobserver variability in DCM patients due to preexist-
ing wall motion abnormalities and substantial number of
patients with left bundle branch. It has been suggested
that dobutamine induced change in wall motion score
index of ≥ 0.44 identifies patients who will do better dur-
ing the follow-up.
Cardiac power output
This index is not sensitive to changes in afterload, and
after optimization for preload accurately reflects contrac-
tile properties of the myocardium [27]. Noninvasive cal-
culation of cardiac power output is relatively complex and
requires special instrumentation [11]. The most practical
formula to calculate cardiac power output in Watts was
suggested by Cook and coworkers [28]:
Cardiac power output = (cardiac output × mean arterial pres-
sure) × 2.22 × 10 -3
where cardiac output is calculated by multiplying aortic
velocity-time integral by aortic valve area, and mean arte-
rial pressure is calculated in a standard manner.
The major problem with this index is that its calculation
is time consuming, requires skilled echocardiographer,
and is subjected to numerous sources of error. Further-
more, very few cardiologist are familiar with this index
which precludes its wider use. Suggested cut-off point
between patients with respect to prognosis is dobutamine
induced change in cardiac power output of ≥ 1 W.
Prognostic significance
There is no doubt that change in left ventricular contrac-
tility during stress has considerable prognostic signifi-
cance and may have profound effect on therapeutic
strategy. We will review available data according to the
means how contractile response was elicited.
Low-dose dobutamine
Most authors prefer low-dose dobutamine stress-echocar-
diography, probably because it is considered safe and is
not time consuming. A report by Paelinck and coworkers
has suggested that low-dose dobutamine can identify
patients with atrial fibrillation induced dilated cardiomy-
opathy who will improve following restoration of sinus
rhythm [29]. These authors concluded that low-dose dob-
utamine may be used to identify patients with
tachycardiomyopathy.
It has been shown, in a small number of patients, that
changes in left ventricular wall motion score index and
ejection fraction during low-dose dobutamine echocardi-
ography are predictive of improvement of left ventricular
systolic performance during medium term follow-up (Fig-
ure 1) [15]. Since the degree of beta-receptor downregula-
tion and desenzititation is a marker of progressive
deterioration of left ventricular systolic function [30], the
authors hypothetized that improvement in contractility
during dobutamine infusion is greater in patients with
preserved beta-receptor function who will subsequently
show improvement in systolic performance.
These findings are further extended, so it has been shown
that the presence of myocardial contractile reserve identi-
fies patients who will respond favorably to beta-blocker
therapy [31]. Furthermore, Drozd and coworkers have
demonstrated that the incidence of cardiac death or need
for cardiac transplantation is lower in patients with pre-
served contractile reserve. In this paper, multivariate anal-
ysis identified left ventricular end-systolic volume of less
than 150 ml after dobutamine infusion and no decrease
of left ventricular end-diastolic volume after dobutamine
infusion as significant predictors of combined end-point
[32].
Contractile reserve has been shown to correlate well with
peak oxygen consumption (Figure 2) [16]. At multivariate
analysis in this report, only percentage change in end-
systolic volume index was significantly associated with
occurrence of cardiac death or hospitalization for worsen-
ing heart failure. The area under receiver-operating charac-
teristic curve was similar for percentage change in end-
systolic volume index and peak oxygen consumption
(0.86 ± 0.04 vs. 0.80 ± 0.06). Additionally, a report by Par-
askevidis and coworkers suggested that low-dose dob-
utamine may further refine prognosis in patients with
maximal oxygen consumption between 10 and 14 ml/kg/
min [13]. This finding may be used for prioritization of
patients for cardiac transplantation.
High-dose dobutamine
Use of high-dose dobutamine is not associated with seri-
ous complications in DCM patients, and has an overall
feasibility of 88.7%. The most common adverse event
requiring discontinuation of dobutamine infusion is
occurrence of complex ventricular arrhythmias, which
was noted in 8% of patients (frequent multifocal ventricu-
lar extrasystoles in 6.4% and nonsustained ventricularPage 3 of 8
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the association of complex ventricular arrhythmias and
serum potassium concentrations, it may be postulated
that complex arrhythmias are more frequent in potassium
depleted patients. Therefore, it appears prudent to check
serum potassium level prior to high-dose dobutamine
stress-echocardiography. Hypotension, defined as
decrease in systolic blood pressure by more than 30
mmHg, is very rare in the absence of complex ventricular
arrhythmias and, in authors experience, occurs in less
than 1% of patients with angiographically documented
idiopathic DCM. Potential advantage of high-dose, as
compared to low-dose, dobutamine echocardiography is
that it may evoke more complete contractile response.
Very intriguing finding is that early in the course of DCM,
dobutamine induced change in left ventricular contractile
response and geometry is able to predict late spontaneous
recovery of left ventricular systolic performance [14]. It is
interesting that this study confirmed previous findings
that increased left ventricular mass is associated with bet-
ter outcome in DCM [33], and suggested that the presence
of left ventricular hypertrophy implies the presence of
myocardial contractile reserve.
The largest study that studied prognostic significance of
high-dose dobutamine included 186 DCM patients. The
major findings of this study are that dobutamine induced
change in wall motion score index is able to identify
Change in ejection fraction during follow-up in patients wih preserved (group A) and diminished (group B) contractile reserveFigur 1
Change in ejection fraction during follow-up in patients wih preserved (group A) and diminished (group B) contractile reserve. 
Abreviations: LVEF, left ventricular ejction fraction. From: Kitaoka H, Takata T, Yabe N, Hitomi N, Furuno T, Doi YL: Low dose dob-
utamine stress echocardiography predicts the improvement of left ventricular systolic function in dilated cardiomyop-
athy. Heart 1999;81:523-27.Page 4 of 8
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up (Figure 3), and that change in wall motion score index
carries superior prognostic information than change in
ejection fraction [10] Additionally, it has been reported
that dobutamine induced change in ejection fraction by ≥
8%, assessed by radionuclide ventriculography, is prog-
nostically superior to maximal oxygen consumption in
patients with severe DCM [34].
Recent data by our group demonstrate that contractile
reserve indices assessed by high-dose dobutamine corre-
late with myocardial histomorphometric features, sug-
gesting that contractile reserve is strongly related to the
degree of hystological disruption in DCM patients. Myo-
cyte diameter and interstitial fibrosis showed strongest
correlation with change in wall motion score index (r = -
0.667, p < 0.001, and r = -0.567, p = 0.004, respectively),
followed by change in ejection fraction (r = -0.603, p =
0.002, and r = -0.467, p = 0.021, respectively) [35].
Dipyridamole
It appears that dipyridamole may be used instead of dob-
utamine to evoke contractile response, since it is less
arrythmogenic [36] better tolerated and yields similar
prognostic information in patients with coronary artery
disease [37]. Ability of dipyridamole to recruit contractile
reserve is mediated through increase in coronary blood
flow and accumulation of endogenous adenosine [38,39].
Linear correlation with 95% confidence interval between peak oxygen consumption and percent change in end-systolic volume ind xFigu e 2
Linear correlation with 95% confidence interval between peak oxygen consumption and percent change in end-systolic volume 
index. Abreviations: % ESVI, percent change in end-systolic volume index; peak VO2, peak oxygen consumption. From: Scrutinio D, Napoli 
V, Passantino A, Ricci A, Lagioia R, Rizzon P: Low-dose dobutamine responsivness in idiopathic dilated cardiomiopathy: rela-
tion to exercise capacity and clinical outcome. Eur Heart J 2000;21:927-34.Page 5 of 8
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stress-echocardiography is that the former is not affected
by the use beta-blocking agents which are frequently used
in DCM patients. Only one study recently examined abil-
ity of dipyridamole to predict prognosis in DCM patients.
The authors concluded that increase in wall motion score
index ≥ 0.15 during dipyridamole stress identifies patients
who are more likely to survive during the mean follow-up
of more than three years [19]. Reported overall feasibility
of dipyridamole stress-echocardiography in this study was
99.2%, which is significantly higher than previously
reported feasibility of dobutamine stress-echocardiogra-
phy.
Exercise
As previously said, there are no echocardiographic studies
on exercise induced contractile response in DCM patients.
However, Nagaoka and colleagues used radionuclide ven-
triculography to measure increase in ejection fraction dur-
ing exercise in DCM patients with mild symptoms, and
concluded that change in ejection fraction <4% identifies
patients with worse prognosis [17]. Additionally, it has
been suggested that variables, such as cardiac power out-
put, obtained by direct hemodynamic measurements dur-
ing exercise may have important prognostic implications
in patients with systolic dysfunction [12].
Kaplan-Meir survival curves (only cardiac deaths were considered) in patients stratified according to the dobutamine induced change in wall motion score indexFigur  3
Kaplan-Meir survival curves (only cardiac deaths were considered) in patients stratified according to the dobutamine induced 
change in wall motion score index. Abbreviations: ∆WMSi, change in wall motion score index. From: Pratali L, Picano E, Otašević P, 
Vigna C, Palinkas A, Cortigiani L, Dodi C, Bojić D, Varga A, Csanady M, Landi : Prognostic significance of the dobutamine 
echocardiography test in idiopathic dilated cardiomyopathy. Am J Cardiol. 200;88:1374-8.Page 6 of 8
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Right ventricular contribution to global cardiac perform-
ance is minor in subjects with normal or mildly depressed
left ventricular systolic function, but may become more
important in patients with advanced left heart failure [40].
Previous studies have suggested that right ventricular
enlargement is a strong marker for adverse prognosis in
DCM patients [41], as well as that right ventricular long
axis excursion is predictive of exercise tolerance [42].
However, there are only limited reports of the prognostic
value of right ventricular contractile reserve in patients
with DCM. DiSalvo and colleagues have demonstrated
that an increase in RVEF to >35% during exercise is the
only independent predictor of event-free survival in
patients with advanced heart failure [43]. It has been also
shown that preserved right ventricular contractile reserve
(measured by pressure-area relations) induced by low-
dose dobutamine infusion was associated with a good 30-
day outcome in patients with NYHA class IV heart failure
[44].
Data from our laboratory support prognostic significance
of high-dose dobutamine induced change in right ven-
tricular fractional area change [45]. It appears that frac-
tional area change of >9% identifies patients with more
favorable outcome. More importantly, these data suggest
that patients in whom contractile reserve of both ventri-
cles is preserved will most likely have good prognosis.
What role for stress-echocardiography?
Despite the wealth evidence that favor use of stress-
echocardiography in patients with DCM, there is no clear-
cut algorithm about its use in risk stratification and thera-
peutic strategy. The reasons for this are not clear, but prob-
ably reflect the lack of standardized protocol and
measurements of left ventricular contractile reserve.
We strongly believe that stress-echocardiography should
be used as a standard procedure, at least in centers which
do not have access to cardiopulmonary testing, since data
obtained when patients are subjected to some form of
stress have far greater prognostic significance than data
obtained at rest. Furthermore, stress-echocardiography
should be used in patients who are not able to exercise or
fail to achieve expected work load. Stress-echocardiogra-
phy may also play an important role for detailed risk strat-
ification in patients with maximal oxygen consumption of
10–14 ml/kg/min. The choice of stress-protocol, at least
for the time being, should be based upon local expertise
and preferences of attending physician.
Future directions
There is an obvious lack of studies that will contribute to
standardization of stress-echocardiographic protocol.
Head-to-head comparison of stressors, including low- and
high-dose dobutamine, dipyridamole, and exercise, has to
be performed in order to rank their ability to predict prog-
nosis. Similar comparisons have to be made for various
indices of left ventricular contractility. Additionally, it is
not clear should the patients be tested with or without
beta-blocker therapy, and how this therapy may affect our
choice of stressor. Last but not the least, novel echocardi-
ographic techniques that can easily assess regional and
global contractility, like tissue Doppler imaging and
strain-rate imaging, have not yet been tested in a prospec-
tive manner.
In conclusion, stress-echocardiography can be a valuable
tool for the assessment of patients with DCM, but a lot of
work has to be done before it becomes a part of a routine
work-up.
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